Insiders · AEON

Robert E. Bancroft

President & CEO, Director at AEON Biopharma, Inc. (AEON) since April 2025

Robert E. Bancroft has filed 4 insider reports with the SEC since May 2025, as president & CEO and director at AEON Biopharma, Inc. (AEON). The latest filing, on February 20, 2026, reports grant or award at AEON Biopharma, Inc. (AEON).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Robert E. Bancroft is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
AEON Biopharma, Inc. logo
AEON
AEON Biopharma, Inc.
President & CEO, Directorsince April 20253,177,103$0.1243Feb 20, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert E. Bancroft with

Other insiders at the same companies

Questions about Robert E. Bancroft

What is Robert E. Bancroft's role at AEON Biopharma, Inc.?
Robert E. Bancroft reports to the SEC as president & CEO and director at AEON Biopharma, Inc. (AEON), according to the latest filing on February 20, 2026.
How many shares does Robert E. Bancroft own?
After the latest filing that states it, Robert E. Bancroft directly owned 3,177,103 shares of AEON Biopharma, Inc. (AEON). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert E. Bancroft bought or sold stock recently?
No open-market purchases or sales by Robert E. Bancroft are on file. The filings report grant or award.
How do I get alerts when Robert E. Bancroft files?
Follow Robert E. Bancroft on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert E. Bancroft (SEC CIK 0002066370). Totals count each trade once, skipping amendments whose original is on file, from May 1, 2025 on. View on SEC EDGAR